Modulation of death receptor-mediated apoptosis in differentiating human myeloid leukemia HL-60 cells

Journal of Leukocyte Biology

Volumn 69, Issue 5, 2001, Pages 794-802

  Vondráček, Jan ^a,b   Sheard, Michael A ^a   Krejčí, Pavel ^a   Minksová, Kateřina ^a   Hofmanová, Jiřina ^a   Kozubík, Alois ^a  

^a MENDEL UNIVERSITY IN BRNO   (Czech Republic)

^b INSTITUTE OF BIOPHYSICS   (Czech Republic)

Author keywords

All trans retinoic acid; Bcl 2; Dimethyl sulfoxide; FAP 1; Fas CD95 APO 1; TNF

Indexed keywords

DIMETHYL SULFOXIDE; FAS ANTIBODY; FAS ANTIGEN; PROTEIN BCL 2; RETINOIC ACID; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CELL DIFFERENTIATION; CELL STRAIN HL 60; CONTROLLED STUDY; HUMAN; HUMAN CELL; MYELOID LEUKEMIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD; ANTIGENS, CD95; APOPTOSIS; CARRIER PROTEINS; CELL DIFFERENTIATION; CULTURE MEDIA, SERUM-FREE; DIMETHYL SULFOXIDE; HL-60 CELLS; HUMANS; KINETICS; LEUKEMIA, MYELOID; PROTEIN-TYROSINE-PHOSPHATASE; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, TUMOR NECROSIS FACTOR; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RNA, MESSENGER; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA; UP-REGULATION;

EID: 0343395853     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (58)

1. Steller, H. (1995) Mechanisms and genes of cellular suicide. Science 267, 1445-1449.
2. Kerr, J. F. K., Wyllie, A. H., Currie, A. R. (1972) Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
3. Schulze-Osthoff, K., Ferrari, D., Los, M., Wesselborg, S., Peter, M. E. (1998) Apoptosis signaling by death receptors. Eur. J. Biochem. 254, 439-459.
4. Jarpe, M. B., Widmann, C., Knall, C., Schlesinger, T. K., Gibson, S., Yujiri, T., Fanger, G. R., Gelfand, E. W., Johnson, G. L. (1998) Anti-apoptotic versus pro-apoptotic signal transduction: checkpoints and stop signs along the road to death. Oncogene 17, 3261-3270.
5. Ashkenazi, A., Dixit, V. M. (1998) Death receptors: signaling and modulation. Science 281, 1305-1308.
6. Ashkenazi, A., Dixit, V. M. (1999) Apoptosis control by death and decoy receptors. Curr. Opin. Cell Biol. 11, 255-260.
7. DegliEsposti, M. (1999) To die or not to die - the quest of the TRAIL receptors. J. Leukoc. Biol. 65, 535-542.
8. Darnay, B. G., Aggarwal, B. B. (1997) Early events in TNF signaling: a story of associations and dissociations. J. Leukoc. Biol. 61, 559 566.
9. Baker, S. J., Reddy, E. P. (1998) Modulation of life and death by the TNF receptor superfamily. Oncogene 17, 3261-3270.
10. Wickremasinge, R. G., Hoffbrand, A. V. (1999) Biochemical and genetic control of apoptosis: relevance to normal hematopoiesis and hematological malignancies. Blood 93, 3587-3600.
11. James, S. Y., Williams, M. A., Newland, A. C., Colston, K. W. (1999) Leukemia cell differentiation: cellular and molecular interactions of retinoids and vitamin D. Gen. Pharmacol. 32, 143-154.
12. Cotter, T. G., Fernandes, T. S., Verhaegen, S., McCarthy, J. M. (1994) Cell death in the myeloid lineage. Immunol. Rev. 142, 93-112.
13. 3, and granulocyte-macrophage colony-stimulating factor. Blood 90, 4578-4587.
14. Martin, S. J., Bradley, J. G., Cotter, T. G. (1990) HL-60 cells induced to differentiate towards neutrophils subsequently die via apoptosis. Clin. Exp. Immunnol. 79, 448-453.
15. Solary, E., Bertrand, R., Kohn, K. W., Pommier, Y. (1993) Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerase I and II inhibitors. Blood 81, 1359-1368.
16. Sordet, O., Bettaieb, A., Bruey, J. M., Eymin, B., Droin, N., Ivarsson, M., Garrido, C., Solary, E. (1999) Selective inhibition of apoptosis by TPA-induced differentiation of U937 leukemic cells. Cell Death Differ. 6, 351-361.
17. Zwelling, L. A., Chan, D., Hinds, M., Mayes, J., Silberman, L. E., Blick, M. (1988) Effect of phorbol ester treatment on drug-induced, topoisomerase II-mediated DNA cleavage in human leukemia cells. Cancer Res. 48, 6625-6633.
18. Kikuchi, H., Iizuka, R., Sugiyama, S., Gon, G., Mori, H., Arai, M., Mizumoto, K., Imajoh-Ohmi, S. (1996) Monocytic differentiation modulates apoptotic response to cytotoxic anti-Fas antibody and tumor necrosis factor alpha in human monoblast U937 cells. J. Leukoc. Biol. 60, 778-783.
19. Wu, Y. L., Jiang, X. R., Allen, P. D., Jia, L., Dronfield, D. M., Newland, A. C., Kelsey, S. M. (1996) Modulation of surface TNF expression by human leukaemic cells alters their sensitivity to exogenous TNF. Leuk. Res. 20, 47-55.
20. Del Bino, G., Li, X., Traganos, F., Darzynkiewicz, A. (1994) Altered susceptibility of differentiating HL-60 cells to apoptosis induced by antitumor drugs. Leukemia 8, 281-288.
21. Sato, A., Imaizumi, M., Saito, T., Yoshinari, M., Suzuki, H., Hayashi, Y., Iinuma, K. (1999) Detection of apoptosis in acute promyelocytic leukemia cells in vivo during differentiation induction with all-trans retinoic acid in combination with chemotherapy. Leuk. Res. 23, 827-832.
22. Fenaux, P., Chastang, C., Chevret, S., Sanz, M., Dombret, H., Archimbaud, E., Fey, M., Rayon, C., Huguet, F., Sotto, J. J., Gardin, C., Makhoul, P. C., Travade, P., Solary, E., Fegueux, N., Bordessoule, D., San Miguel, J., Link, H., Desablens, B., Stamatoullas, A., Deconinck, E., Maloisel, F., Castaigne, S., Preudhomme, C., Degos, L. (1999) A randomized comparison of all trans retinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. Blood 94, 1192-1200.
23. Sato, T., Irie, S., Kitada, S., Reed, J. C. (1995) FAP-1: a protein tyrosine phosphatase that associates with Fas. Science 268, 411-415.
24. NTR and their effect on NF-κB activation. FEBS Lett. 460, 191-198.
25. Yonehara, S., Ishii, A., Yonehara, M. (1989) A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. Exp. Med. 169, 1747-1756.
26. Gong, J., Traganos, F., Darzynkiewicz, Z. (1994) A selective procedure for DNA extraction from apoptotic cells applicable for gel electrophoresis and flow cytometry. Anal. Biochem. 218, 314-319.
27. O'Keefe, D. A., James, D. R., Ware, W. R., Petersen, N. O. (1991) Kinetics of a rapid, luminol-dependent chemiluminescence signal induced in HL-60 cells by amphotericin B and other stimulants. Biochem. Cell Biol. 69, 618-623.
28. Hofmanova, J., Kozubik, A., Dusek, L., Pachernik. J. (1998) Inhibitors of lipoxygenase metabolism exert synergistic effects with retinoic acid on differentiation of human leukemia HL-60 cells. Eur. J. Pharmacol. 350, 273-284.
29. Nagy, L., Thomazy, V. A., Heyman, R. A., Davies, P. J. (1998) Retinoid-induced apoptosis in normal and neoplastic tissues. Cell Death Differ. 5, 11-19.
30. Watson, R. W. G., Rotstein, O. D., Parodo, J., Bitar, R., Hackam, D., Marshall, J. C. (1997) Granulocytic differentiation of HL-60 cells results in spontaneous apoptosis mediated by increased caspase expression. FEBS Lett. 412, 603-609.
31. Bruel, A., Benoit, G., De Nay, D., Brown, S., Lanotte, M. (1995) Distinct apoptotic responses in maturation sensitive and resistant t(15;17) acute promyelocytic leukemia NB4 cells. 9-cis retinoic acid induces apoptosis independent of maturation and Bcl-2 expression. Leukemia 9, 1173-1184.
32. Depraetere, S., Joniau, M. (1995) Potentiation of tumor necrosis factor-mediated cytotoxicity on human myeloid cell lines: effects of interferons versus dimethyl sulphoxide. Leuk. Res. 19, 803-809.
33. Depraetere, S., Vanahaesebroeck, B., Fiers, W., Willems, J., Joniau, M. (1995) Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines. J. Leukoc. Biol. 57, 141-151.
34. Winzen, R., Wallach, D., Engelmann, H., Nophar, Y., Brakebusch, C., Kemper, O., Resch, K., Holtmann, H. (1992) Selective decrease in cell surface expression and mRNA level of the 55-kDa tumor necrosis factor receptor during differentiation of HL-60 cells into macrophage-like but not granulocyte-like cells. J. Immunol. 148, 3454-3460.
35. Furukawa, Y., Iwase, S., Terui, Y., Kikuchi, J., Sakai, T., Nakamura, M., Kitagawa, S., Kitagawa, M. (1996) Transcriptional activation of the cdc2 gene is associated with Fas-induced apoptosis of human hematopoietic cells. J. Biol. Chem. 271, 28469-28477.
36. Nakamura, S., Takeshima, M., Nakamura, Y., Ohtake, S., Matsuda, T. (1997) Induction of apoptosis in HL60 leukemic cells by anticancer drugs in combination with anti-Fas monoclonal antibody. Anticancer Res. 17, 173-179.
37. McGahon, A. J., Pereira, A. P. C., Daly, L., Cotter, T. G. (1998) Chemotherapeutic drug-induced apoptosis in human leukaemic cells is independent of the Fas (APO-1/CD95) receptor/ligand system. Br. J. Haematol. 101, 539-547.
38. Komada, Y., Inaba, H., Zhou, Y. W., Zhang, X. L., Tanaka, S., Azuma, E., Sakurai, M. (1997) mRNA expression of Fas receptor (CD95)-associated proteins (Fas-associated phosphatase-1/FAP-1, Fas-associating protein with death domain/FADD, and receptor-interacting protein/RIP) in human leukaemia/lymphoma cell lines. Br. J. Haematol. 99, 325-330.
39. Laouar, A., Glesne, D., Huberman, E. (1999) Involvement of protein kinase C-beta and ceramide in tumor necrosis factor-alpha-induced but not Fas-induced apoptosis of human myeloid leukemia cells. J. Biol. Chem. 274, 23526-23534.
40. Deptala, A., Halicka, H. D., Ardelt, B., Ardelt, W., Mikulski, S. M., Shogen, K., Darzynkiewicz, Z. (1998) Potentiation of tumor necrosis factor induced apoptosis by onconase. Int. J. Oncol. 13, 11-16.
41. Saeki, K., Yuo, A., Kato, M., Miyazono, K., Yazaki, Y., Takaku, F. (1997) Cell density-dependent apoptosis in HL-60 cells, which is mediated by an unknown soluble factor, is inhibited by transforming growth factor beta 1 and overexpression of bcl-24. J. Biol. Chem. 272, 20003-20010.
42. Dirks, W., Schone, S., Uphoff, C., Quentmeier, H., Pradella, S., Drexler, H. G. (1997) Expression and function of CD95 (FAS/APO-1) in leukaemia-lymphoma tumour lines. Br. J. Haematol. 96, 584-593.
43. Munker, R., Andreeff, M. (1996) Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma. Cytokines Mol. Ther. 2, 147-159.
44. Robertson, M. J., Manley, T. J., Pichert, G., Cameron, C., Cochran, K. J., Levine, H., Ritz, J. (1995) Functional consequences of APO-1/Fas (CD95) antigen expression by normal and neoplastic hematopoietic cells. Leuk. Lymphoma 17, 51-61.
45. Perkins, C., Kim, C. N., Fang, G., Bhalla, K. N. (1998) Overexpression of Apaf-1 promotes apoptosis of untreated and paclitaxel-or etoposide-treated HL-60 cells. Cancer Res. 58, 4561-4566.
46. Burow, M. E., Weldon, C. B., Tang, Y., Navar, G. L., Krajewski, S., Reed, J. C., Hammond, T. G., Clejan, S., Beckman, B. S. (1998) Differences in susceptibility to tumor necrosis factor alpha-induced apoptosis among MCF-7 breast cancer cell variants. Cancer Res. 58, 4940-4946.
47. Breitman, T. R., Selonick, S. E., Collins, S. J. (1980) Induction of differentiation of the human promyelocytic leukemia cell line (HL-60) by retinoic acid. Proc. Natl. Acad. Sci. USA 77, 2936-2940.
48. Collins, S. J., Ruscetti, F. W., Gallagher, R. E., Gallo, R. C. (1978) Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc. Natl. Acad. Sci. USA 75, 2458-2462.
49. Dufer, J., Biakou, D., Joly, P., Benoist, H., Carpentier, Y., Desplaces, A. (1989) Quantitative morphological aspects of granulocytic differentiation induced in HL-60 cells by dimethyl sulfoxide and retinoic acid. Leuk. Res. 13, 621-627.
50. Delia, D., Aiello, A., Soligo, D., Fontanella, E., Melani, C., Pezzella, F., Pierotti, M. A., Della Porta, G. (1992) bcl-2 proto-oncogene expression in normal and neoplastic human myeloid cells. Blood 79, 1291-1298.
51. Naumovski, L., Cleary, M. L. (1994) Bcl2 inhibits apoptosis associated with terminal differentiation of HL-60 myeloid leukemia cells. Blood 83, 2261-2267.
52. Chatterjee, D., Han, Z. Y., Mendoza, J., Goodglick, L., Hendrickson, E. A., Pantazis, P., Wyche, J. H. (1997) Monocytic differentiation of HL-60 promyelocytic leukemia cells correlates with the induction of Bcl-x(L). Cell Growth Differ. 8, 1083-1089.
53. Zhou, Y. W., Komada, Y., Inaba, H., Azuma, E., Sakurai, M. (1998) Down-regulation of Fas-associated phosphatase-1 (FAP-1) in interleukin-2-activated T cells. Cell. Immunol. 186, 103-110.
54. Myc, A., Arscott, P. L., Bretz, J. D., Thompson, N. W., Baker, J. R., Jr. (1999) Characterization of FAP-1 expression and function in thyroid follicular cells. Endocrinology 140, 5431-5434.
55. Cuppen, E., Nagata, S., Wieringa, B., Hendriks, W. (1997) No evidence for involvement of mouse protein-tyrosine phosphatase-BAS-like Fas-associated phosphatase-1 in Fas-mediated apoptosis. J. Biol. Chem. 272, 30215-30220.
56. Hedlund, T. E., Duke, R. C., Schleicher, M. S., Miller, G. J. (1998) Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage. Prostate 36, 92-101.
57. Houghton, J. A., Harwood, F. G., Gibson, A. A., Tillman, D. M. (1997) The Fas signaling pathway is functional in colon carcinoma cells and induces apoptosis. Clin. Cancer Res. 3, 2205-2209.
58. Mundle, S. D., Mativi, B. Y., Bagai, K., Feldman, G., Cheema, P., Gautam, U., Reza, S., Cartlidge, J. D., Venugopal, P., Shetty, V., Gregory, S. A., Robin, E., Rifkin, S., Shah, R., Raza, A. (1999) Spontaneous down-regulation of Fas-associated phosphatase-1 may contribute to excessive apoptosis in myelodysplastic marrows. Int. J. Hematol. 70, 83-90.